Roivant anticipates $950M Moderna payment in July as it outlines 2H 2026 mosliciguat and IMVT-1402 readouts (NASDAQ:ROIV)
Earnings Call Insights: Roivant Sciences Ltd. (ROIV) Q4 2025 Management View CEO Matthew Gline said the quarter included “the preliminary ...
